- Home
- BST vs MDXG Comparison
BST vs MDXG Comparison
Compare BST & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BST
- MDXG
- Stock Information
- Founded
- BST 2014
- MDXG 2006
- Country
- BST United States
- MDXG United States
- Employees
- BST N/A
- MDXG N/A
- Industry
- BST Finance Companies
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- BST Finance
- MDXG Health Care
- Exchange
- BST Nasdaq
- MDXG Nasdaq
- Market Cap
- BST 1.3B
- MDXG 877.4M
- IPO Year
- BST N/A
- MDXG N/A
- Fundamental
- Price
- BST $38.27
- MDXG $6.98
- Analyst Decision
- BST
- MDXG Strong Buy
- Analyst Count
- BST 0
- MDXG 2
- Target Price
- BST N/A
- MDXG $12.50
- AVG Volume (30 Days)
- BST 91.6K
- MDXG 649.3K
- Earning Date
- BST 01-01-0001
- MDXG 07-30-2025
- Dividend Yield
- BST 7.87%
- MDXG N/A
- EPS Growth
- BST N/A
- MDXG N/A
- EPS
- BST N/A
- MDXG 0.27
- Revenue
- BST N/A
- MDXG $352,375,000.00
- Revenue This Year
- BST N/A
- MDXG $9.55
- Revenue Next Year
- BST N/A
- MDXG $11.43
- P/E Ratio
- BST N/A
- MDXG $25.81
- Revenue Growth
- BST N/A
- MDXG 5.34
- 52 Week Low
- BST $27.87
- MDXG $5.47
- 52 Week High
- BST $39.59
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- BST 68.12
- MDXG 69.74
- Support Level
- BST $37.91
- MDXG $5.86
- Resistance Level
- BST $38.56
- MDXG $6.42
- Average True Range (ATR)
- BST 0.38
- MDXG 0.23
- MACD
- BST -0.01
- MDXG 0.14
- Stochastic Oscillator
- BST 95.79
- MDXG 94.68
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.